Form D · Other
Guanyin Labs, Inc.
San Francisco, CA · CIK 0001789538
Offering snapshot reported Jan 6, 2020 · SEC filing
- Reported sold
- $150K Offering amount: $150K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $150K Reported outside-investor minimum
- First sale
- Jan 6, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 6, 2020 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Sep 27, 2019 | Initial | $5,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-357249
Convertible Promissory Note and the capital stock of the issuer into which the Convertible Promissory Note may convert (Note Stock), as well as any capital stock of the issuer into which the Note Stock may convert.
Source: Form D, filed Jan 6, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brenda Jin | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
3145 Geary Blvd #747
San Francisco, CA, 94118
San Francisco, CA, 94118